Intravascular robotics leader Hansen Medical announced that Will Sutton has been appointed to the newly created position of Chief Operating Officer. Reporting directly to President and CEO Bruce Barclay, Mr. Sutton will manage and oversee the company’s engineering and manufacturing functions. Hansen Medical created this position to enhance collaboration on product development and manufacturing, which is consistent with its commitment to bringing innovative products and capabilities to the market with improved product margins.
“I am excited to join the Hansen Medical team at such an important inflection point in the Company’s history,” said Mr. Sutton. “I look forward to utilizing my experience in operations management, research, product development, and manufacturing to help Hansen Medical achieve operational and commercial excellence.”
Prior to joining Hansen, Mr. Sutton has spent the past 10 years at St. Jude Medical in increasingly senior positions. As Vice President of Research and Development of the Atrial Fibrillation (AF) Division, Mr. Sutton directed strategic R&D activities for global interventional electrophysiology products. He also managed a 270-person department and a portfolio of over 30 annual projects. During his six years in this role, revenue in the St. Jude’s AF Division grew from $145 million to over $880 million. Mr. Sutton also served as the Director of R&D for the St. Jude’s Cardiac Surgery Division and Vice President of Program Management for the AF Division. In this role, he oversaw day-to-day strategic R&D activities and ensured project performance to timeline, budget, features, and success metrics.
Mr. Sutton began his career as a development engineer in the Diagnostics Division of Abbott Labs, and holds a B.S. and M.S. in mechanical engineering from Stanford University.
“Will has extensive operations, research, product development, and manufacturing experience in the medical technology space, both in capital equipment and disposables, and within both the EP and vascular markets,” said Mr. Barclay. “His background is ideal for the newly created COO position. As Hansen Medical sharpens its operational and commercial focus, it is imperative that we have the organizational structure, and experienced leadership to maximize profitability and ensure long-term commercial success.”
He continued, “Will’s appointment, as well as the recently announced appointment of Bob Cathcart to the position of Senior Vice President of Global Sales, provides Hansen Medical with two additional, highly experienced senior executives with proven commercial success in support of this objective. I am confident that Will’s expertise will be invaluable to our Company as we expand the launch of our Magellan™ Robotic System, and continue to advance our product pipeline.”
For more information on Hansen Medical, visit www.hansenmedical.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
